Is Microbot Medical Inc (MBOT) overvalued? · rev $346.0K
Microbot Medical Inc (MBOT) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether Microbot Medical Inc (MBOT) looks expensive on cached numbers — not a short thesis.
Latest reported MBOT revenue for 2026-06-30 was $346.0K. Net income was -$9.3M. MBOT currently screens at market cap $123.9M.
MBOT currently screens at market cap $123.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next MBOT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the MBOT stock page for the full model, not this heading.
Not investment advice.